Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognition Disorders × DNA Methylation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Central Nervous System Neoplasms 2 Oligodendroglioma 1 Gliosarcoma 1 Cognition Disorders 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Mental Status and Dementia Tests 1 Lomustine 1 DNA Methylation 1 Cognitive Training 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01290939 2021-02-15

Bevacizumab and Lomustine for Recurrent GBM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed

Brain Neoplasms, Cognition Disorders, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡